ArticlePLOS global public health2025
Timeliness of yellow fever specimen collection and transport in Ghana, 2018-2022.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Yellow Fever Outbreaks and Reactive Vaccination in Africa, 2010-2025: A Scoping Review and Analysis.Research square · 2026Article
- Revisiting the Status of Yellow Fever Epizootics and Its Surveillance in South America: New Non-Human Primates, Spillover and Ecological Drivers.Pathogens (Basel, Switzerland) · 2026Review
- Yellow Fever in Pregnancy: A Comprehensive Review of the Clinical Implications and Vaccination in the Context of the 2024-2026 Americas Outbreak.Tropical medicine and infectious disease · 2026Review
- Timeliness of yellow fever specimen collection and transport in Ghana, 2018-2022.PLOS global public health · 2025Article
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
Yellow fever is a mosquito-borne viral hemorrhagic fever, and recent outbreaks of yellow fever have occurred in multiple African countries, including Ghana (2021-2022). Delayed diagnosis of yellow fever may cause increased morbidity and mortality. To improve timely detection of yellow fever, we need to better understand the factors contributing to diagnostic delays. We analyzed the diagnostic testing timeline of all suspected yellow fever cases in Ghana from 2018-2022. For these patients we calculated the days from symptom onset to specimen collection and arrival at the National Public Health and Reference Laboratory for testing. We compared these times to World Health Organization (WHO) metrics. For suspected yellow fever cases, the time from symptom onset to specimen arrival had a median of 10 days (interquartile range 6-17). 5892/6345 (93%) of specimens were collected within 14 days of symptom onset, and 2653/6471 (41%) of specimens arrived within 3 days of collection (WHO metrics). Overall, we find that the timing of yellow fever testing varies among districts in Ghana. While specimens are generally collected in a timely manner, delays in specimen arrival are common. Improving specimen transport for yellow fever and/or expanded testing could lead to more timely detection of outbreaks.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.